Screener
OnKure Therapeutics, Inc. OKUR Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -42.7%— | -74.4%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 13.8×+2.6× | 10.3×-0.5× | 11.4×-12.3× | 11.1×-46.7× | 11.2×-18.6× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×— | 0×— | 0×— | |
| Per Share | ||||||
| Book value per share | $13.48+99.7% | $4.16-86.2% | $4.91+101% | $5.79+101% | $6.75+102% | |
| Valuation | ||||||
| Market capitalization | $93.14M-30.2% | $123.71M-65.8% | $117.16M— | $108.91M— | $181.92M— | |
| Price / book | 0.5×-1.5× | 2.2×-1.3× | 1.8×— | 1.4×— | 2×— |
FAQ
- Where do OnKure Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from OnKure Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.